Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Editorials

Refining post-blinatumomab risk stratification through ultrasensitive-based measurable residual disease assessment

Department of Stem Cell Transplant and Cellular Therapy, Kaiser Permenante, Los Angeles, CA
Division of leukemia, Department of Hematology and HCT, City of Hope, Duarte, CA
Haematologica Early view Apr 16, 2026 https://doi.org/10.3324/haematol.2026.300941

Abstract

Not available.

Figures & Tables

Article Information

Early view : Editorials
 
DOI
https://doi.org/10.3324/haematol.2026.300941
 
Published
2026-04-16
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
39
PDF Downloads
18
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online